Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women

References

• Yonkers KA, O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet. 2008;371(9619):1200–1210. doi:10.1016/S0140-6736(08)60527-9
   PubMed Web of Science ®Google Scholar
• O’Brien PM, Backstrom T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women Mental Health. 2011;14(1):13–21. doi:10.1007/s00737-010-0201-3
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R, Merikangas KR, Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand. 2001;104(2):110–116. doi:10.1034/j.1600-0447.2001.00412.x
   PubMed Web of Science ®Google Scholar
• Association AP. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Arlington: American Psychiatric Association; 2013.
   Google Scholar
• Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. Am Fam Physician. 2016;94(3):236–240.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Simoni MK. Premenstrual disorders. Am J Obstet Gynecol. 2018;218(1):68–74. doi:10.1016/j.ajog.2017.05.045
   PubMed Web of Science ®Google Scholar
• Kelderhouse K, Taylor JS. A review of treatment and management modalities for premenstrual dysphoric disorder. Nurs Women Health. 2013;17(4):294–305. doi:10.1111/1751-486X.12048
   Google Scholar
• Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005;72(6):414–421. doi:10.1016/j.contraception.2005.08.021
   PubMed Web of Science ®Google Scholar
• Pearlstein TB, Halbreich U, Batzar ED, et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J Clin Psychiatry. 2000;61(2):101–109. doi:10.4088/JCP.v61n0205
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Halbreich U, Freeman E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997;278(12):983–988. doi:10.1001/jama.1997.03550120043031
   PubMed Web of Science ®Google Scholar
• Shehata NA. Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;198:100–104. doi:10.1016/j.ejogrb.2016.01.015
   PubMed Web of Science ®Google Scholar
• Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2006;9(1):41–49. doi:10.1007/s00737-005-0103-y
   PubMed Web of Science ®Google Scholar
• Schmidt K, Weber N, Steiner M, et al. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): results of a randomized, placebo-controlled, double-blind clinical trial. Clin Nutr ESPEN. 2018;24:22–30. doi:10.1016/j.clnesp.2018.01.067
   PubMed Web of Science ®Google Scholar
• Henz A, Ferreira CF, Oderich CL, et al. Premenstrual syndrome diagnosis: a comparative study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST). Rev Bras Ginecol Obstet. 2018;40(1):20–25. doi:10.1055/s-0037-1608672
   PubMedGoogle Scholar
• Wu L, He Z, Zhao H, et al. Chinese version of daily record of severity of problems: reliability and validity. J Adv Nurs. 2013;69(2):449–456. doi:10.1111/j.1365-2648.2012.06070.x
   PubMed Web of Science ®Google Scholar
• Takeda T, Shiina M, Chiba Y. Effectiveness of natural S-equol supplement for premenstrual symptoms: protocol of a randomised, double-blind, placebo-controlled trial. BMJ Open. 2018;8(7):e023314. doi:10.1136/bmjopen-2018-023314
   PubMed Web of Science ®Google Scholar
• Takeda T, Shiina M, Yamada K. Development of the Japanese version of the Daily Record of Severity of Problems (DRSP): translation and linguistic validation. Clin Gynecol Obstet. 2019;73(8):807–811.
   Google Scholar
• Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health. 2006;9(4):209–212. doi:10.1007/s00737-006-0137-9
   PubMed Web of Science ®Google Scholar
• Bixo M, Ekberg K, Poromaa IS, et al. Treatment of premenstrual dysphoric disorder with the GABA(A) receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial. Psychoneuroendocrinology. 2017.
   Web of Science ®Google Scholar
• Takeda T, Koga S, Yaegashi N. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese high school students. Arch Women Mental Health. 2010;13(6):535–537. doi:10.1007/s00737-010-0181-3
   Web of Science ®Google Scholar
• Takeda T, Yoshimi K, Yamada K. Psychometric testing of the premenstrual symptoms questionnaire and the association between perceived injustice and premenstrual symptoms: a cross-sectional study among Japanese High School Students. Int J Womens Health. 2020;12:755–763. doi:10.2147/IJWH.S269392
   PubMed Web of Science ®Google Scholar
• Marsh HW, Hocevar D. Application of confirmatory factor analysis to the study of self-concept: first- and higher order factor models and their invariance across groups. Psychol Bull. 1985;97(3):562–582. doi:10.1037/0033-2909.97.3.562
   Web of Science ®Google Scholar
• Hooper DCJ, Mullen MR. Structural equation modelling: guidelines for determining model fit. Electron J Bus Res Methods. 2008;6(1):53–60.
   Google Scholar
• Hu L-T, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6(1):1–55. doi:10.1080/10705519909540118
   Web of Science ®Google Scholar
• Condon JT. Investigation of the reliability and factor structure of a questionnaire for assessment of the premenstrual syndrome. J Psychosomatic Res. 1993.
   Web of Science ®Google Scholar
• York R, Freeman EL, Lowery BA, Strauss JF 3rd. Characteristics of premenstrual syndrome. Obstet Gynecol. 1989.
   Google Scholar
• Ikeda Y, Egawa M, Hiyoshi K, et al. Development of a Japanese version of the daily record of severity of problems for diagnosing premenstrual syndrome. Women Health Rep. 2020;1(1):11–16. doi:10.1089/whr.2019.0004
   Google Scholar